The most profound anti-tumor effects of quarfloxin are associated with MYCN amplification (103), implying the above drugs that target MYCC G-quadruplex can also be used to target MYCN G-quadruplex for treatment of MYCN-driven tumors. This evidence concerns the gene MYCN and neoplasm.